Ascendis Pharma A/s · NASDAQ:ASND
T. Rowe Price Investment Management, Inc. reported a 5.00% stake in Ascendis Pharma A/s (Schedule 13G)
Event Mar 31, 2025 · Filed May 14, 2025
T. Rowe Price Investment Management, Inc. reported a 5.00% stake in Ascendis Pharma A/s, 3,053,824 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 3,053,824
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.00% | 3,053,824 |
Source
Related
- Ascendis Pharma A/s
- T. Rowe Price Investment Management, Inc.
- Ascendis Pharma A/s shareholders
- Schedule 13G · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2025
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Bienaime Jean Jacques · Aug 18, 2026
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Bienaime Jean Jacques · Jun 1, 2026